Growing Concern Over Food Allergies Among Young People
Approximately 8% of children and adolescents in the UK are affected by food allergies, with some facing the grave risk of anaphylaxis—a severe and potentially life-threatening reaction that necessitates immediate treatment with adrenaline. Recognising the critical need for effective emergency response, the Medicines and Healthcare products Regulatory Agency (MHRA) has initiated a consultation aimed at allowing schools to acquire and maintain spare adrenaline nasal sprays for emergency situations involving children with severe allergies. This initiative is a collaborative effort that spans the entirety of the UK, in partnership with the Department of Health in Northern Ireland.
Emergency Preparedness in Educational Settings
Currently, schools are permitted to stock spare adrenaline auto-injectors for emergencies. Given that approximately 20% of serious allergic reactions to food occur within educational environments, the consultation seeks public opinion on the potential of schools to possess adrenaline nasal sprays in a similar capacity.
Under the proposed guidelines, educational institutions would have the flexibility to choose whether to stock adrenaline auto-injectors, nasal sprays, or both. Existing precautions would remain in place, ensuring that emergency adrenaline can only be administered to children identified as being at risk of anaphylaxis, and only by trained staff members.
Voices from the Frontline of Allergy Care
Julian Beach, Executive Director of Operations at the MHRA, emphasised the importance of ensuring that children with allergies have rapid access to appropriate medication in emergencies. He stated, “Adrenaline nasal sprays would serve as an additional treatment option for those at risk of anaphylaxis, a condition with serious implications. Through this consultation, we aim to determine whether schools should be authorised to purchase and store these products alongside existing auto-injectors.”
Amena Warner, Head of Clinical Services at Allergy UK, highlighted the anxiety parents feel when dropping their allergy-sensitive children off at school. She noted that the introduction of a needle-free adrenaline device for nasal administration could ease concerns and enhance confidence among both parents and children when it comes to addressing allergic reactions swiftly.
Support from Educational Leadership
Paul Whiteman, General Secretary of the NAHT, a union of school leaders, expressed support for the consultation, underscoring the vital role schools play in supporting pupils with serious allergies. He stressed the necessity for any proposals to be safe, practical, and well-supported by clear guidance and training for school staff.
Professor Adam Fox OBE, Chair of the National Allergy Strategy Group, acknowledged the significant progress made in ensuring schools have spare adrenaline pens available. He advocated for schools to remain updated with newer treatment options while ensuring clarity to prevent confusion among staff and students alike.
Broadening the Scope of Adrenaline Products
The consultation also invites contributions regarding the potential for legislation to adopt broader terminology for self-administered adrenaline products that may become available in the future. This change would facilitate a quicker consideration process for any new authorised adrenaline products without necessitating separate legislative amendments each time.
It is important to note that the proposals would not mandate schools to stock a specific product or brand, nor would they replace the requirement for children to carry their own prescribed adrenaline medication. The supplies held at schools would serve strictly as backup in emergency situations.
Invitation for Public Participation
The consultation is set to remain open for eight weeks, welcoming insights from a diverse audience including schools, staff, parents, healthcare professionals, and anyone interested in enhancing access to emergency treatment for anaphylaxis. New allergy safety requirements for schools in England are scheduled to take effect in September 2026 as part of the initial phase of Benedict’s Law.
The full consultation will be accessible from 19 October and will close on 14 December 2026, providing an opportunity for all stakeholders to voice their opinions on this crucial matter.